(Q46825082)

25 December 2017

title

25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma (English)

1 reference

25 December 2017

0 references

K Khadzkou

1

1 reference

25 December 2017

P Buchwald

2

1 reference

25 December 2017

G Westin

3

1 reference

25 December 2017

H Dralle

4

1 reference

25 December 2017

G Akerström

5

1 reference

25 December 2017

P Hellman

6

1 reference

25 December 2017

publication date

28 November 2005

1 reference

25 December 2017

Journal of Histochemistry and Cytochemistry

published in

1 reference

25 December 2017

volume

54

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

355-361

1 reference

25 December 2017

Renal and nonrenal 25-hydroxyvitamin D-1alpha-hydroxylases and their clinical significance

cites work

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Vitamin D receptor expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Recent developments in the use of vitamin D analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.5A6734.2005

21 January 2018

Identifiers

DOI

10.1369/JHC.5A6734.2005

1 reference

25 December 2017

PubMed ID

16314444

1 reference

25 December 2017